Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1991 Publications

  1. Holm, C., Covey, J.M., Kerrigan, D., Kohn, K.W., and Pommier, Y., 1991. Protection by DNA synthesis inhibition against cell killing by topoisomerase blocking drugs. In: Potmesil, M., Kohn, K.W., Liu, L., Muggia, F. and Silber, R. (eds): DNA Topoisomerases in Cancer. New York: Oxford University Press, pp. 161-171.
  2. Zaharko, D.S., Kelley, J.A., Tomaszewski, J.E., Hegedus, L., and Hartman, N.R., 1991. Cyclopentenyl Cytosine: Interspecies Predictions Based on Rodent Plasma and Urine Kinetics. Invest. New Drugs, 9: 9-17.
  3. Wientjes, M.G., M.E. Placke, M.J-W. Chang, J.G. Page, W.M. Kluwe and J.E. Tomaszewski, 1991. Pharmacokinetics of 2',3'-Dideoxyadenosine in Dogs. Invest. New Drugs, 9, 159-168.
  4. Ford, H., Jr., D.A. Cooney, G.S. Ahluwalia, Z. Hao, M.E. Rommel, L. Hicks, K.A. Dobyns, J.E. Tomaszewski and D.G. Johns, 1991. Cellular Pharmacology of Cyclopentenyl Cytosine in Molt-4 Lymphoblasts. Cancer Res., 51: 3733-3740.
  5. Luster, M.I., G.J. Rosenthal, W. Cao, M.B. Thompson, A.E. Munson, J.D. Prejean, G. Shopp, B.A. Fuchs, D.R. Germolec and J.E. Tomaszewski, 1991. Experimental Studies of the Hematologic and Immune System Toxicity of Nucleoside Derivatives Used Against HIV Infection. Int. J. Immunopharmacol., 13, Suppl. 1, 99-107.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov